AtaiBeckley Inc. Common Stock

ATAINASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
3.95 USD
↘ 0.55 (12.22%)AT CLOSE (11:59 AM EDT)
3.98
↗ 0.03 (0.76%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
3.98
↗ 0.03 (0.76%)
🔴Market: CLOSED
Open?$4.46
High?$4.49
Low?$3.78
Prev. Close?$4.50
Volume?9.2M
Avg. Volume?N/A
VWAP?$4.03
Bid / Ask
Bid?$3.97 × 1.0K
Ask?$4.00 × 800
Spread?$0.03
Midpoint?$3.99
Valuation & Ratios
Market Cap?1.5B
Shares Out?368.2M
Float?298.7M
Float %?81.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

ATAI is currently priced at $3.95. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
99
Market Cap
1.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ataibeckley.com
Listed
2021-06-18
Address
C/O ATAI LIFE SCIENCES US, INC.
NEW YORK, NY 10119
Phone: 1 929 207 2670
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?7.81%Elevated
Short Interest?23.3M
Days to Cover?5.8
Free Float298.7M
Avg Daily Volume4.0M
Settlement Date2026-05-15
MarketsMoversWatchlist